ECVT

Image source: The Motley Fool. Wednesday, Aug. 5, 2026 at 11:00 a.m. ET Chief Executive Officer - Kurt Bitting Chief Financial Officer - Michael Feehan Senior Director of Investor Relations - H. Gene Shiels Operator: Good morning, everyone. My name is Beau, and I will be your conference operator today. Welcome to Ecovyst's Second Quarter 2026 Earnings Call and Webcast. Please note, today's call is being recorded and should run approximately 1 hour. [Operator Instructions] I would now like to hand the conference over to Mr. Gene Shiels, Senior Director of Investor Relations. Please go ahead, sir. H. Shiels: Thank you, operator. Good morning, and welcome to Ecovyst's second quarter 2026 earnings call. With me on the call this morning are Kurt Bitting, Ecovyst's Chief Executive Officer; and Mike Feehan, Ecovyst's Chief Financial Officer. Following our prepared remarks this morning, we'll take your questions. Please note some of the information shared today is forward-looking information, including information about the company's financial and operating performance, strategies, our anticipated end-use demand trends and our 2026 financial outlook. This information is subject to risks and uncertainties that could cause the actual results and the implementation of the company's plans to vary materially. Any forward-looking information shared today speaks only as of this date. These risks are discussed in the company's filings with the SEC. Reconciliations of non-GAAP financial measures mentioned in this morning's call with their corresponding GAAP measures can be found in our earnings release and in the presentation materials posted in the Investors section of our website. I'll now turn the call over to Kurt. Kurt Bitting: Thank you, Gene, and good morning. We are very pleased with our second quarter results, which reflect continued progress against our financial objectives and clear execution of our long-term growth strategy. As anticipated, high refinery utilization and favorable alkylate economics contributed to growth in sales volume for regenerated sulfuric acid. In addition, virgin sulfuric acid volume increased on a double-digit percentage basis compared to the year ago quarter on positive demand and the contribution from Waggaman acquired in May of last year. This volume growth, along with favorable net pricing, resulted in adjusted EBITDA of $53 million, solidly within our guidance range and up 27% compared to the second quarter of 2025. The quarter was also a milestone in strategic execution. On June 30, we closed the acquisition of the Calabrian sulfur dioxide and related derivatives business, the third bolt-on in a playbook we have now run 3 times, which is to identify essential sulfur chemistries adjacent to what we already do best, acquire them at capital-efficient valuations and integrate them into a network that is uniquely built to provide superior products and services to our customers. Calabrian broadens our portfolio, deepens our position in end uses we already serve and is accretive from day 1. Slide 5 lays out that playbook. The disposition of our Advanced Materials & Catalysts segment in December simplified the portfolio and strengthened the balance sheet, giving us both the focus and the financial flexibility to build a platform of leading sulfur solutions. Ecoservices has long been a leading provider of virgin and regenerated sulfuric acid, and it is that scale in sulfur chemistry that makes each step out possible. The first was Chem32 in 2021, a leading provider of ex-situ catalyst activation using sulfur-based sulfiding technology. The second was Waggaman in May of 2025, which added capital-efficient incremental capacity sited in our Gulf Coast network. Waggaman contributed to our double-digit virgin sulfuric acid volume growth this quarter, and we have delivered the network optimization we underwrote. Calabrian is the third step, and it follows the same logic. It brings significant end-use and customer overlap with our legacy business, while adding sulfur dioxide and derivative chemistries we did not previously offer. That is what makes this more than added capacity. It widens what we can sell to customers we already serve in applications where reliability of supply, not price alone, decides who wins the contract. Across our portfolio, we hold leadership positions in critical chemistries that are essential to our customers' operations, positions that are uniquely built to provide superior products and services to our customers and that we intend to keep extending. On Slide 6, our demand expectations have not changed materially from our first quarter call. For sales of regenerated sulfuric acid, we are in the midst of the summer driving season, and alkylate economics remain favorable. We expect refinery utilization to remain high and for the second half, higher regenerated sulfuric acid volume with lower unplanned customer downtime than we experienced in 2025. For sales of virgin sulfuric acid overall, we expect relative stability for the balance of the year. We see continued demand growth in the mining sector driven by copper expansion projects tied to structural electrification. Calabrian gives us a second way to participate in that same growth. With Canadian gold mines running at full capacity, we expect its sulfur dioxide sales into mining to remain favorable. For sales into industrial applications, we continue to expect virgin sulfuric acid sales into the nylon end-use to be relatively flat in 2026. Sulfur prices continue to increase. And while we did not see any material demand destruction in the second quarter associated with high sulfur prices, we remain cautious about the potential for weaker demand in some industrial applications. Based on experience, we expect today's elevated sulfur prices to eventually moderate. If customers begin to anticipate lower sulfur prices, we could see a temporary demand impact from destocking. Overall, long-term secular trends, mining expansion and the onshoring of U.S. industrial activity are positives for Ecovyst. And as a leading provider of products essential to our customers, we remain excited about the longer-term outlook across our businesses. I'll now turn the call over to Mike, who will review our financial results. Michael Feehan: Thank you, Kurt, and good morning. Starting with our key highlights. Our second quarter sales of $250 million were up $74 million, reflecting the pass-through impact of higher sulfur costs, favorable net pricing and strong demand for both regenerated sulfuric acid and virgin sulfuric acid. Adjusted EBITDA of $53 million was up 27% and solidly within our guidance range. Cash generation was positive in the quarter. And for the first half of 2026, adjusted free cash flow was $13 million. Considering the closing of the Calabrian acquisition at the end of the second quarter, funded through debt and cash on hand, we ended the quarter with a net debt leverage ratio of 2x. On the following slide, excluding the $55 million sulfur pass-through, sales were up nearly 11%, reflecting higher regenerated and virgin sulfuric acid volume in part from the acquired Waggaman plant and favorable contractual pricing. Adjusted EBITDA was up $11 million, driven by higher sales volume and favorable net pricing, partially offset by higher manufacturing costs, general inflation and higher transportation costs. The adjusted EBITDA bridge on the following slide shows a continued positive price-to-cost ratio at the contribution margin level. As previously mentioned, the pass-through effect of higher sulfur costs on sales was approximately $55 million, with the pass-through generally having no material impact on adjusted EBITDA. Excluding that pass-through, the price and variable cost combination contributed $9 million, largely from favorable contractual pricing for regenerated sulfuric acid, including the net price impact of higher index costs. Higher sales volume, including Waggaman, accounted for nearly $7 million, partially offset by higher fixed manufacturing costs, including Waggaman's incremental costs. Turning to the cash and leverage on the next slide. As noted, cash generation was positive in the second quarter, resulting in adjusted free cash flow for the first 6 months of 2026 of $13 million. As we have previously discussed, free cash flow generation this year will reflect higher capital expenditures associated with the expansion of our Gulf Coast storage and logistics network and the working capital impact of higher sulfur costs. We ended the quarter with available liquidity of $176 million, $88 million of cash and $88 million of availability under our ABL. Because the funding of the Calabrian acquisition added $100 million of debt with no associated trailing 12-month EBITDA contribution, our net debt leverage ratio at quarter end was 2x, up from 1.2x at March 31. It is worth noting that the 2x leverage ratio carries the full acquisition debt against none of Calabrian's trailing 12-month EBITDA. We are currently at the low end of our 2 to 2.5x target range. Turning to the next slide. Our capital allocation over the past 15 months reflects the same discipline Kurt described, $83 million of stock repurchases, $472 million of debt reduction and 2 bolt-on acquisitions, aggregating $224 million. In addition, this year, we have the flexibility to implement plans to organically invest approximately $20 million in the expansion of our Gulf Coast storage and logistics network. We executed buybacks, delevered and made 2 acquisitions and still ended the quarter at the bottom of our target leverage range. Going forward, we expect to maintain that balance, weighing organic growth projects, additional bolt-on acquisitions, debt reduction and stock repurchases, creating the most value for our stockholders. I'll now turn to the 2026 outlook and revised guidance. Our revised 2026 guidance reflects both our expectations for our legacy business and the expected contribution of the Calabrian business in the third and fourth quarters. Sulfur prices rose further in the second quarter, and our second half outlook assumes they hold near current levels. On that basis, we now expect the full year pass-through effect of sulfur cost on sales to be approximately $220 million higher compared to the prior year, up from $155 million previously expected. Incorporating Calabrian, we now expect full year 2026 sales of $1.02 billion to $1.06 billion, up from our prior guidance, which excluded Calabrian of $890 million to $970 million. Given our favorable first half results and our confidence in continued demand stability, we are raising the low end of our full year adjusted EBITDA guidance range for the legacy business to $185 million, while maintaining the high end at $195 million. For Calabrian, we expect adjusted EBITDA in the second half of the year to be in the range of $10 million to $12 million. Accordingly, we now expect Ecovyst full year 2026 adjusted EBITDA to fall in the range of $195 million to $207 million. We expect adjusted free cash flow to be in the range of $45 million to $55 million, up from $40 million to $55 million, with the increase reflecting the contribution from Calabrian, partially offset by the impact of increased sulfur costs on working capital. While we funded a portion of the Calabrian acquisition through a $100 million add-on to our term loan, we have realized some additional interest savings. And as such, our expectations for the full year interest expense remains unchanged at $18 million to $22 million. Capital expenditures are now expected to be $85 million to $95 million, up from $80 million to $90 million, reflecting the Gulf Coast expansion and the addition of Calabrian. Depreciation and amortization is now estimated at $80 million to $84 million. And we expect our full year effective tax rate to remain in the mid-20% range. And finally, we expect adjusted net income to be in the range of $65 million to $85 million with adjusted diluted net income per share of $0.58 to $0.72 per share. As we move to the next slide, I'll provide directional guidance for the third and fourth quarters. For the third quarter, we expect sales of regenerated sulfuric acid to be up compared to the third quarter of 2025. And although we expect third quarter volume to be up sequentially, we anticipate virgin sulfuric acid will be slightly lower than the year ago quarter, reflecting fewer expected spot sales compared to the third quarter of 2025. With higher turnaround costs than the prior year, we expect third quarter 2026 adjusted EBITDA, including Calabrian, to be in the range of $54 million to $59 million. Fourth quarter expectations are similar, higher regenerated sulfuric acid volume and lower virgin sulfuric acid volume than in the fourth quarter of 2025. Second half virgin volumes are expected to be lower than the last year because 2025 had a high amount of spot opportunities, and we did not have the turnarounds limiting our production. We believe sulfur prices may have reached a plateau and could begin to decrease later this year. We still expect sulfuric acid pricing, excluding the pass-through effect, to be lower in the fourth quarter on projected customer mix and on the timing difference between when we purchase sulfur and when we pass those costs through to customers. Regarding turnaround costs, you will note a change in the turnaround schedule compared to our view in the first quarter's earnings call, as 1 of the 2 turnarounds planned for the fourth quarter has now shifted into early 2027. Despite this timing shift, we still expect turnaround costs in the fourth quarter to be up compared to the year ago quarter, as Q4 2025 did not have any turnarounds. For the fourth quarter of 2026, we expect adjusted EBITDA, including Calabrian to be between $48 million and $55 million. I will hand the call back to Kurt for some closing remarks. Kurt Bitting: Thank you, Mike. We are encouraged by our progress through the first half of the year with results that position us well for the second half. Building on the strong performance of our legacy business and the expected contribution from Calabrian in the third and fourth quarters, we have increased our full year 2026 adjusted EBITDA guidance to a range of $195 million to $207 million. We are pleased to welcome the Calabrian team to Ecovyst. One month in, integration is on plan, and we are focused on executing the synergy actions we underwrote at signing and identifying the growth projects that Calabrian's asset base supports. For the remainder of the year, our focus will remain on execution. In addition to the integration of Calabrian, the Gulf Coast storage and logistics expansion is underway, which we expect will enhance our ability to serve growing virgin sulfuric acid demand. After funding the Calabrian acquisition, we ended the second quarter with a net debt leverage ratio of 2x, within our long-term guidance range of 2 to 2.5x. As we continue to evaluate organic and inorganic growth opportunities, we believe our balance sheet and cash generation capability will continue to provide significant flexibility, and we will prioritize the options we believe create the best value for our stockholders. I will close on this. Our advantage is not any single asset or transaction. It is a network of essential sulfur chemistries embedded in our customers' operations, a position we have now extended 3x without stretching the balance sheet. We intend to keep compounding it. At this time, I will ask the operator to open the line for questions. Operator: [Operator Instructions] We'll go first this morning to John McNulty with BMO Capital Markets. Margarita Margulis: This is Margarita Margulis on for John. Given the volatility in the sulfur and sulfuric acid markets, could you please speak to not only spot pricing, but since roughly 90% of your business is tied to longer-term contracts, how should we think about where contracts coming due later this year may reset? Kurt Bitting: Thanks for the question. So yes, spot sulfur and sulfuric prices are obviously up appreciably year-over-year. And as you pointed out, the lion's share of our business is really -- is under contract, right, anywhere from 1-year to 3-year contracts for virgin sulfuric acid. And a portion of those roll off at the end of every year. So it would be our belief and expectation is as those roll off, they should be negotiated as usual at more favorable pricing and terms if everything in terms of the market overall is in the same condition as it is today. Margarita Margulis: Great. And then I had another question on nylon markets. We have seen concerns about some weakness there. Could you speak to what you're seeing currently? Kurt Bitting: Yes. For our area in nylon, which is, again, really geographically focused on the Gulf Coast production, we went into this year believing it would be flattish for us. And that's -- as we sit here midway through the year, that's largely how it's playing out. So we maintain that outlook for the remainder of the year. Operator: We'll go next now to Patrick Cunningham with Citi. Patrick Cunningham: Now that the Calabrian transaction is closed, integration is underway, can you quantify or provide an update on targeted cost synergies, how we should be thinking about those in 2027? And sort of how soon you expect to leverage your existing sales force and customer base to accelerate some of the cross-selling you talked about in the past? Kurt Bitting: Yes, sure. Well, thanks, Patrick. I mean we're -- again, we're excited about Calabrian -- day 1 was -- is completed. We've safely integrated the business with no customer disruptions. The leadership has been retained. We're happy with the demand. It's tracking to our modeling, and we're really excited about, obviously, the future of growth in terms of the gold sector, particularly in Canada. And as we stated before, we expect to deliver both cost and revenue synergies, likely in the $3 million to $4 million range. So to put that in perspective, we stated that we purchased the business for around 8x. And after the synergies are implemented, that will step down to around 7x. Patrick Cunningham: Understood. Very helpful. And then maybe just a question on the guidance. Correct me if I'm wrong, I think the underlying guidance rate, excluding Calabrian is maybe a couple of million higher in the second half. Is that exclusively coming from one less turnaround in 4Q? Or is there anything else that you'd call out in terms of incremental puts and takes? Kurt Bitting: No. So yes, thanks for pointing that. I mean, we -- this is -- we're pleased with our results and outlook so far. And this is -- we did tighten the guidance range now for the second consecutive quarter, which obviously implies an upward move on the midpoint. I would say that's a combination of system cost items as well as additional favorability that we're seeing in some of the spaces, particularly as it pertains to like regeneration, which has obviously been favorable this year with the nice backdrop in refining. So we're happy with where we're at. And right now, at the midpoint, we're looking at our legacy business really moving up about 11% year-on-year based on our midpoint that we've offered. Operator: [Operator Instructions] We'll go next now to David Silver with Freedom Capital Markets. David Silver: I was just wondering, I think in your prepared remarks, you talked about sulfur and sulfuric acid costs moderating, I think, towards the end of the year or a little bit beyond. Apologies if I missed it, but could you just kind of maybe discuss what your assumptions are for how that market might balance out? Kurt Bitting: Sure. Thanks, David. Welcome back. I think for sulfur, what we made the comment -- I made the comment that we believe that sulfur is largely plateauing right now at its current levels here, at least where we purchased domestically in the U.S. International sulfur prices remain very elevated. U.S. prices have followed that upward. However, you start to see some fertilizer, which is obviously a huge user of the sulfur molecule, have announced some curtailments just based on fertilizer economics, sulfur economics and so forth. However, despite those curtailments, mining demand for sulfur remains strong. So we just think the blend of those 2 dynamics going on with the curtailments in the fertilizer industry with plus still demand strong from other sectors of the global economy, particularly in mining, is going to lead to a moderation of sulfur prices. We don't believe that the price really has much room to go up from here, but we could see some moderate decreases in the future, but not -- we're not expecting a large handle down or anything like that. David Silver: Okay. And I mean, there is -- as you pointed out, there is this spread, I guess, between the domestic contract price and maybe the international spot price. And with your enlarged and enhanced kind of sulfuric acid network, I mean, I am kind of scratching my head and I'm wondering if there's maybe some flexibility within your system to maybe take advantage of that spread via maybe exports out of one or more of your Louisiana-based facilities. But is there some flexibility in the system to consider that option on an opportunistic basis here? Kurt Bitting: Sure. And we have participated in exports in the past out of -- with sulfuric acid. And again, the Waggaman facility brought that capability to our portfolio last year when we acquired that business. So as you point out, domestic sulfur prices are lower than international prices, which creates a bit of an advantage for people producing sulfuric acid here in the U.S., but also for the people consuming sulfuric acid in the U.S. So it gives our customers a leg up versus their international competition because their raw materials, particularly on sulfur and energy and so forth, tend to be cheaper. And additionally, I would point out probably the largest advantage our network has is the availability of sulfur and the fact that we have the high concentration in the Gulf Coast, which is where the lion's share of sulfur is produced in North America. David Silver: Okay. Great. And then maybe last question for me. But in your remarks, you talked about the Calabrian acquisition being accretive from day 1. And I just wanted to check that frequently, when there's a new acquisition, there are some upfront costs. But should we think that Calabrian is going to be free cash flow positive in the first year of ownership as well? Or might there be some upfront costs to complete the integration the way you want? Michael Feehan: Yes. David, it's Mike. Thanks for the question. Yes, we do believe the Calabrian acquisition is going to be cash flow positive for us. Certainly, we guided an EBITDA number of somewhere between $10 million and $12 million for the second half of the year. Of course, from a cash flow standpoint, there will be some additional taxes paid. We did take on $100 million of additional debt, which would increase our interest, but we also saw some cash interest savings across the portfolio. So we left our overall guidance unchanged. There is some capital that we will spend there, but the Calabrian business is less capital intensive than the legacy acid business. So that's going to be a very net positive for us. I will say that the Calabrian business overall has a slightly higher EBITDA margin percent than the legacy business. So again, it generates a higher level of free cash flow. It does represent roughly 10% of our overall business, but it's a very positive accretive acquisition. There will be some upfront costs, but they're not overly significant, and they'll be well outpaced by the synergies that we're expecting to get over the next year or 2. David Silver: I appreciate you putting together all the moving parts there. That's what I was trying to figure out. Operator: Thank you. And gentlemen, it appears we have no further questions this morning. So ladies and gentlemen, that will bring us to the conclusion of today's call. We'd like to thank you all so much for joining the Ecovyst second quarter earnings conference call and wish you all a great remainder of your day. Goodbye. Before you buy stock in Ecovyst, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Ecovyst wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $403,337!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,334,946!* Now, it’s worth noting Stock Advisor’s total average return is 958% — a market-crushing outperformance compared to 214% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors. See the 10 stocks » *Stock Advisor returns as of August 12, 2026. This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Ecovyst (ECVT) Q2 2026 Earnings Call Transcript was originally published by The Motley Fool

Interested in Ecovyst Inc.? Here are five stocks we like better. Second-quarter performance improved: Ecovyst reported $250 million in sales and $53 million in adjusted EBITDA, up 27% year over year, driven by higher sulfuric acid volumes, favorable pricing and strong refinery utilization. Calabrian acquisition expands the sulfur portfolio: The newly acquired sulfur dioxide business was immediately accretive, with management targeting $3 million to $4 million in cost and revenue synergies and $10 million to $12 million of second-half adjusted EBITDA contribution. Full-year guidance was raised: Ecovyst now expects 2026 sales of $1.02 billion to $1.06 billion and adjusted EBITDA of $195 million to $207 million, while sulfur-cost pass-through is projected to add approximately $220 million to sales versus 2025. Oil Prices Are Surging and These 4 Stocks Are Cashing In Ecovyst (NYSE:ECVT) reported second-quarter 2026 sales of $250 million and adjusted EBITDA of $53 million, with the company citing higher sulfuric acid volumes, favorable net pricing and elevated refinery utilization. Adjusted EBITDA increased 27% from the second quarter of 2025 and fell within the company’s guidance range. Chief Executive Officer Kurt Bitting said strong refinery activity and favorable alkylate economics supported sales volumes for regenerated sulfuric acid during the quarter. Virgin sulfuric acid volume also rose by a double-digit percentage from a year earlier, aided by demand and the contribution from the Waggaman facility acquired in May 2025. → Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth “This volume growth, along with favorable net pricing, resulted in Adjusted EBITDA of $53 million,” Bitting said. On June 30, Ecovyst closed its acquisition of the Calabrian sulfur dioxide and related derivatives business. Bitting described the deal as the company’s third bolt-on acquisition under its strategy of adding sulfur chemistries adjacent to its existing operations. → Sandisk Just Delivered a Blowout Quarter—Here's Why the Stock Is Falling The acquisition follows Ecovyst’s 2021 purchase of Chem32, which provides ex situ catalyst activation using sulfur-based sulfiding technology, and the 2025 Waggaman acquisition, which added sulfuric acid capacity in the company’s Gulf Coast network. According to Bitting, Calabrian broadens Ecovyst’s product offering by adding sulfur dioxide and derivative chemistries, while bringing overlap in customers and end markets. He said the business was accretive from its first day under Ecovyst ownership. → 4 Oil and Gas ETF Plays as Prices Stay Sky-High Management said integration was proceeding according to plan one month after closing, with no customer disruptions and retained leadership. Bitting said the company expects to generate both cost and revenue synergies of approximately $3 million to $4 million. He said those synergies would reduce the acquisition multiple from roughly eight times to about seven times. Chief Financial Officer Mike Feehan said Calabrian is expected to be cash-flow positive, though Ecovyst will incur some upfront integration costs, capital spending, taxes and interest expense associated with acquisition financing. Feehan said the business is less capital-intensive than Ecovyst’s legacy acid operations and has a somewhat higher EBITDA margin percentage. Feehan said second-quarter sales increased by $74 million from the prior-year quarter. The increase reflected approximately $55 million of sulfur-cost pass-through, as well as favorable net pricing and higher demand for regenerated and virgin sulfuric acid. Excluding the sulfur pass-through, sales rose nearly 11%, according to the company. Higher volume, including the Waggaman facility’s contribution, accounted for nearly $7 million of adjusted EBITDA improvement. Favorable contractual pricing and the relationship between pricing and variable costs contributed another $9 million, Feehan said. Those gains were partly offset by higher manufacturing costs, inflation and transportation expenses. The sulfur pass-through generally had no material impact on adjusted EBITDA, Feehan said. For the first six months of 2026, Ecovyst generated $13 million of adjusted free cash flow. The company ended the quarter with $176 million in available liquidity, including $88 million of cash and $88 million available under its asset-based lending facility. Ecovyst’s net debt leverage ratio was 2.0 times at quarter-end, compared with 1.2 times on March 31. Feehan attributed the increase primarily to the $100 million of debt used to help fund the Calabrian transaction, with no associated trailing 12-month EBITDA from the acquired business included in the leverage calculation. The company said it remains at the low end of its long-term 2.0-times to 2.5-times leverage target. Ecovyst raised its full-year 2026 outlook to incorporate expected results from Calabrian in the third and fourth quarters. The company now expects annual sales of $1.02 billion to $1.06 billion, compared with prior guidance of $890 million to $970 million that excluded Calabrian. The company raised the lower end of its legacy-business adjusted EBITDA outlook to $185 million while maintaining the upper end at $195 million. Calabrian is expected to contribute $10 million to $12 million of adjusted EBITDA during the second half. As a result, Ecovyst now forecasts total 2026 adjusted EBITDA of $195 million to $207 million. Adjusted free cash flow: $45 million to $55 million, up from prior guidance of $40 million to $55 million. Capital expenditures: $85 million to $95 million, up from $80 million to $90 million. Interest expense: $18 million to $22 million, unchanged. Depreciation and amortization: $80 million to $84 million. Adjusted net income: $65 million to $85 million. Adjusted diluted net income per share: $0.58 to $0.72. For the third quarter, Ecovyst expects regenerated sulfuric acid sales to increase from the prior-year period, while virgin sulfuric acid volumes are expected to be slightly lower because of fewer projected spot sales. The company forecast third-quarter adjusted EBITDA, including Calabrian, of $54 million to $59 million. Fourth-quarter expectations similarly call for higher regenerated sulfuric acid volume and lower virgin sulfuric acid volume than in the year-earlier period. Ecovyst projected fourth-quarter adjusted EBITDA of $48 million to $55 million, including Calabrian. Management said sulfur prices continued to rise in the second quarter, and Ecovyst’s outlook assumes prices remain near current levels in the second half. The company now expects sulfur-cost pass-through to add approximately $220 million to 2026 sales compared with the prior year, up from its previous estimate of $155 million. Bitting said domestic sulfur prices appear to have plateaued, though international prices remain elevated. He cited fertilizer-industry curtailments as a possible factor that could support future price moderation, while mining demand remains strong. The company does not anticipate a large decline in sulfur prices, he said. Ecovyst expects regenerated sulfuric acid demand to benefit from high refinery utilization and favorable alkylate economics. It also expects continued mining-sector demand, including copper expansion projects tied to electrification and sulfur dioxide demand from Canadian gold mines operating at full capacity. For nylon-related industrial demand, Bitting said Ecovyst’s Gulf Coast business has performed largely in line with its expectation for a relatively flat 2026. The company said it remains cautious that elevated sulfur prices could eventually affect demand in some industrial applications or lead customers to temporarily reduce inventory if they expect sulfur prices to fall. Ecovyst Inc is a global specialty chemicals company that develops, manufactures and markets performance-enhancing products for industrial applications. The company’s core offerings include catalysts, phosphorus-based additives and barium carbonate materials, all designed to improve process efficiency, product quality and environmental performance. Ecovyst serves a diverse customer base in the energy, refining, chemical, polymer, food and consumer goods industries. The company’s Catalysts segment supplies fluid catalytic cracking (FCC) and hydroprocessing catalysts that help petroleum refiners maximize fuel yield, reduce sulfur emissions and meet increasingly stringent environmental standards. This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected]. The article "Ecovyst Q2 Earnings Call Highlights" was originally published by MarketBeat. View MarketBeat's top stocks for August 2026.

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Performance growth was driven by high refinery utilization and favorable alkylate economics, which boosted regenerated sulfuric acid volumes. The acquisition of Calabrian represents a strategic step into adjacent sulfur dioxide chemistries, leveraging existing customer overlap in mining and industrial sectors. Virgin sulfuric acid saw double-digit volume growth, supported by the integration of the Waggaman facility and strong demand from copper mining electrification projects. Management highlighted the 'reliability of supply' as a key competitive moat, particularly in applications where operational consistency outweighs price sensitivity. The disposition of the Advanced Materials & Catalysts segment in late 2025 provided the financial flexibility to pursue the current sulfur-focused bolt-on strategy. While high sulfur prices have not yet caused material demand destruction, management remains cautious regarding potential customer destocking if prices begin to moderate. Full-year 2026 adjusted EBITDA guidance was raised to $195-$207 million, incorporating a $10-$12 million second-half contribution from the Calabrian acquisition. Management expects sulfur prices to plateau at current levels, with potential for moderate decreases later in the year as fertilizer industry demand softens. Second-half virgin sulfuric acid volumes are projected to be lower than the prior year due to fewer spot market opportunities and the impact of scheduled turnarounds in 2026 that were not present in 2025. The Gulf Coast storage and logistics expansion is underway to enhance the company's ability to capture growing demand for virgin sulfuric acid. One of two planned fourth-quarter turnarounds has been shifted to early 2027, though Q4 costs will still rise year-over-year due to the absence of turnarounds in the prior period. The Calabrian acquisition was funded via $100 million in new debt and cash, bringing the net debt leverage ratio to 2x, the low end of the target range. Sulfur cost pass-throughs are expected to impact sales by approximately $220 million for the full year, though this is generally EBITDA-neutral. Free cash flow guidance of $45-$55 million accounts for higher capital expenditures related to Gulf Coast expansion and the working capital impact of elevated sulfur costs. Management flagged potential 'temporary demand impact' if industrial customers anticipate lower future sulfur prices and begin destocking inventories. One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here. Management expects contracts rolling off at year-end to be renegotiated at more favorable pricing and terms, assuming current market conditions persist. Approximately 90% of the business is tied to long-term contracts (1-3 years), providing a buffer against immediate spot market volatility. Targeted cost and revenue synergies are estimated in the $3 million to $4 million range, which is expected to bring the effective purchase multiple down from 8x to 7x. Integration is proceeding without customer disruption, with a focus on cross-selling into the Canadian gold mining sector. Domestic U.S. sulfur prices are currently lower than international prices, providing a cost advantage for Ecovyst's U.S.-based customers. The Waggaman facility provides the network with export capabilities, allowing the company to opportunistically participate in international markets when spreads are favorable.

Ecovyst (NYSE:ECVT) reported stronger-than-expected second-quarter results and raised its financial outlook for 2026, helping the specialty chemicals company’s shares gain around 2.4% in pre-market trading on Wednesday. The producer of sulfuric acid and sulfur dioxide posted adjusted earnings of $0.21 per share, exceeding the Wall Street consensus estimate of $0.19. Revenue increased 42% year over year to $250 million, ahead of analyst expectations of $237.48 million. During the quarter, Ecovyst completed the acquisition of the Calabrian sulfur dioxide and related derivatives business from INEOS Enterprises, with the transaction closing on 30 June 2026. The acquisition contributed to the company’s improved outlook and expanded its position in the specialty chemicals market. Following the strong quarterly performance, Ecovyst increased its full-year adjusted EBITDA guidance to between $195 million and $207 million, compared with its previous forecast of $180 million to $195 million. The company also lifted its revenue outlook to a range of $1.02 billion to $1.06 billion, up from earlier guidance of $890 million to $970 million. The midpoint of the new forecast exceeds the analyst consensus estimate of $975.2 million. Adjusted earnings per share are now expected to range from $0.58 to $0.72 for the year. While the midpoint of $0.65 sits slightly below the Wall Street consensus of $0.68, investors focused on the stronger revenue and EBITDA outlook. Chief Executive Officer Kurt J. Bitting said the company continued to execute successfully against both its financial and strategic objectives. “In the second quarter of 2026 Ecovyst continued to deliver on its financial and long-term strategic objectives,” Bitting said. “As anticipated, high refinery utilization and positive alkylate economics contributed to increased volume of regenerated sulfuric acid, while virgin sulfuric acid volume increased double digits.” Revenue growth was supported by higher sales volumes and stronger pricing compared with the prior-year period. The company said average selling prices benefited from the pass-through of approximately $55 million in higher sulfur costs as well as favourable contractual pricing for regenerated sulfuric acid. Adjusted EBITDA increased 27% year over year to $53.1 million from $41.9 million. Net income from continuing operations rose to $10.7 million, or $0.10 per diluted share, compared with $5.0 million in the second quarter of 2025. Cash generated from operating activities during the first six months of 2026 also improved significantly, increasing to $55.2 million from $25.3 million in the corresponding period last year. Ecovyst stock price

WAYNE, Pa., Aug. 5, 2026 /PRNewswire/ -- Ecovyst Inc. (NYSE: ECVT) ("Ecovyst" or the "Company"), a leading provider of regenerated sulfuric acid, virgin sulfuric acid, and sulfur dioxide and related derivatives, today reported results for the second quarter ended June 30, 2026. On December 31, 2025, the Company completed the sale of its Advanced Materials & Catalysts business, which includes the Company's investment in affiliated companies, Zeolyst International and Zeolyst C.V. Financial results of the divested Advanced Materials & Catalysts business are reported in discontinued operations in the financial statements for all periods presented. Second Quarter 2026 Results & Highlights from Continuing Operations Sales grew 42% to $250.0 million, an increase of $73.9 million, from $176.1 million in the second quarter of 2025 Net income of $10.7 million, compared to $5.0 million in the year-ago quarter, with a net income margin of 4.3% and diluted net income per share of $0.10 Adjusted Net Income was $23.4 million, compared to $11.4 million in the year-ago quarter, with Adjusted Diluted Income per share of $0.21 Adjusted EBITDA grew 27% to $53.1 million, an increase of $11.2 million from $41.9 million in the second quarter of 2025 Cash flow from operating activities was $55.2 million for the six months ended June 30, 2026, compared to $25.3 million for the six months ended June 30, 2025. Adjusted Free Cash Flow was $12.8 million for the six months ended June 30, 2026, compared to $(2.4) million for the six months ended June 30, 2025 Completed the strategic acquisition of the Calabrian sulfur dioxide and related derivatives business from INEOS Enterprises on June 30, 2026 "In the second quarter of 2026 Ecovyst continued to deliver on its financial and long-term strategic objectives. As anticipated, high refinery utilization and positive alkylate economics contributed to increased volume of regenerated sulfuric acid, while virgin sulfuric acid volume increased double digits, reflecting positive demand fundamentals and the contribution from the Waggaman sulfuric acid plant we acquired in May 2025. As a result, we delivered second quarter 2026 Adjusted EBITDA of $53 million, within our guidance range, and up 27% compared to the year ago quarter," said Kurt J. Bitting, Ecovyst's Chief Executive Officer. "We remain focused on creating long-term stockholder value by delivering differentiated growth by capitalizing on favorable trends in our end-use segments and pursuing synergistic acquisitions that expand our ability to serve those attractive industries," said Bitting. "In Q2 2026, we completed our acquisition of the Calabrian sulfur dioxide and related derivatives business. This transaction broadens Ecovyst's platform of leading sulfur-based solutions, expands our presence in core applications such as mining and water treatment, and provides us with attractive growth opportunities in adjacent industry applications such as food processing and pharmaceuticals. As we begin the integration of Calabrian into Ecovyst, we expect to realize meaningful synergies that we believe will create additional value for our stockholders," said Bitting. "Based upon our favorable results for the first six months of the year, and to reflect the anticipated financial contribution of Calabrian in the second half of the year, we are raising our guidance for full-year Adjusted EBITDA to a range of $195 million to $207 million," added Bitting. Review of Business Results Second quarter 2026 sales were $250.0 million, up $73.9 million or 42%, compared to $176.1 million in the second quarter of 2025. The increase in sales reflects higher sales volume and pricing compared to the prior year quarter. Average selling prices were higher primarily due to the pass-through effect of higher sulfur costs of approximately $55 million and favorable contractual pricing for regenerated sulfuric acid. The increase in sales volume was driven by higher sales of regenerated sulfuric acid from strong demand and less customer downtime, along with higher sales of virgin sulfuric acid due to increased customer demand and the contribution of sales volume from the Waggaman location, compared to the prior year quarter. Second quarter 2026 Adjusted EBITDA was $53.1 million, up $11.2 million or 27%, compared to $41.9 million in the second quarter of 2025, with the increase primarily driven by higher sales volume and favorable net pricing, partially offset by higher manufacturing costs, general inflation and higher transportation costs. Cash Flows and Balance Sheet Cash flows from operating activities for continuing operations were $55.2 million for the six months ended June 30, 2026, compared to $25.3 million for the six months ended June 30, 2025. The increase was primarily driven by higher earnings exclusive of non-cash expenses. As of June 30, 2026, the Company had cash and cash equivalents of $87.8 million. Total gross debt was $497.1 million and availability under the Asset-Based Lending ("ABL") facility was $88.5 million, after giving effect to $2.2 million of outstanding letters of credit and with no revolving credit facility borrowings outstanding. Total cash and cash equivalents of $87.8 million plus the $88.5 million of availability under the ABL facility provided for total available liquidity of $176.3 million. As of June 30, 2026, the net debt to net income ratio was 15.9x and the net debt leverage ratio was 2.0x. The increase in the net debt leverage ratio from 1.2x at December 31, 2025 is due to the $100 million increase in the term loan associated with the acquisition of the Calabrian business with no associated Adjusted EBITDA in the trailing twelve-month period related to the Calabrian business. Revised 2026 Financial Outlook For the second half of 2026 our outlook for demand for regenerated and virgin sulfuric acid remains positive. We expect strong demand for regenerated acid to support alkylate production and lower customer downtime, compared to the second half of 2025. However, and consistent with our previous guidance, we expect lower sales of virgin sulfuric acid in the third and fourth quarters, compared to 2025, primarily reflecting lower expected spot sales opportunities. We remain cautious about the potential for softer demand in some industrial applications for virgin sulfuric acid. In light of the acquisition of the Calabrian sulfur dioxide and related derivatives business on June 30, 2026, we are revising our consolidated full-year 2026 guidance to reflect our expectations for Calabrian's contributions in the third and fourth quarters of 2026. The Company's revised 2026 guidance is as follows: Sales1 of $1,020 million to $1,060 million (change from $890 million to $970 million) Adjusted EBITDA2 of approximately $195 million to $207 million (change from $180 million to $195 million), including an impact from Calabrian in the second half of 2026 of $10 million to $12 million Adjusted Free Cash Flow2 of $45 million to $55 million (change from $40 million to $55 million) Capital expenditures of $85 million to $95 million (change from $80 million to $90 million) Interest expense of $18 million to $22 million Depreciation & Amortization of $80 million to $84 million (change from $78 million to $82 million) Effective tax rate in the mid 20% range Adjusted Net Income2 of $65 million to $85 million (change from $55 million to $75 million), with Adjusted Diluted Income per share2 of $0.58 to $0.72 (change from $0.50 to $0.65) Stock Repurchase In April 2022, the Company's Board of Directors approved a stock repurchase program authorizing the repurchase of up to $450 million of the Company's outstanding common stock. In October 2025, the Company's Board of Directors approved the removal of the expiration date of the stock repurchase program. As of June 30, 2026, $146.5 million was available for stock repurchases under the program. During the second quarter of 2026, the Company did not repurchase any shares of its common stock pursuant to the stock repurchase program. For the six months ended June 30, 2026, the Company repurchased 3,226,461 shares of its common stock on the open market at an average price of $11.07 per share, for a total cost of $35.7 million. During the second quarter of 2025, the Company repurchased 2,926,152 shares of its common stock on the open market at an average price of $7.47 per share, for a total cost of $21.9 million. For possible future repurchases, the actual timing, number, and nature of shares repurchased will depend on a variety of factors, including stock price, trading volume, and general business and market conditions and may be conducted through negotiated transactions, open market repurchases or other means, including through Rule 10b-18 and Rule 10b5-1 trading plans or accelerated stock repurchases. The repurchase program does not obligate the Company to acquire any number of shares in any specific period, or at all, and the repurchase program may be amended, suspended or discontinued at any time at the Company's discretion. Conference Call and Webcast Details On Wednesday, August 5, 2026, Ecovyst management will review the second quarter 2026 results during a conference call and audio-only webcast scheduled for 11:00 a.m. Eastern Time. Conference Call: Investors may listen to the conference call live via telephone by dialing 1 (800) 245-3047 (domestic) or 1 (203) 518-9765 (international) and use the participant code ECVTQ226. Webcast: An audio-only live webcast of the conference call and presentation materials can be accessed at https://investor.ecovyst.com. A replay of the conference call/webcast will be made available at https://investor.ecovyst.com/events-presentations. Investor Contact: Gene Shiels (484) 617-1225 [email protected] About Ecovyst Inc. Ecovyst Inc. and subsidiaries is a leading provider of regenerated sulfuric acid, virgin sulfuric acid and sulfur dioxide and related derivatives, which we believe are essential to our customers' operations and processes. Our family of virgin sulfuric acid products, regenerated sulfuric acid and related derivatives serve a wide range of industrial applications. We are a leading provider of regenerated sulfuric acid to the North American refining industry for the production of alkylate, an essential gasoline component for lowering vapor pressure and increasing octane to meet stringent gasoline specifications and fuel efficiency standards. We are a leading North American producer of high quality and high strength virgin sulfuric acid for industrial and mining applications. Through our Calabrian business, we are also a leading producer of sulfur dioxide and related derivatives in North America, serving key end uses including mining, water treatment and specialty chemical production. We also provide chemical waste handling and treatment services, as well as ex-situ catalyst activation services for the refining and petrochemical industry. For more information, see our website at https://www.ecovyst.com. Presentation of Non-GAAP Financial Measures In addition to the results provided in accordance with U.S. generally accepted accounting principles ("GAAP") throughout this press release, the Company has provided non-GAAP financial measures — Adjusted EBITDA, Adjusted Net Income, Free Cash Flow, Adjusted Free Cash Flow, Adjusted Diluted Income per share, Net Debt, Net Debt to Net Income Ratio and Net Debt Leverage Ratio (collectively, "Non-GAAP Financial Measures") — which present results on a basis adjusted for certain items. The Company uses these Non-GAAP Financial Measures for business planning purposes and in measuring its performance relative to that of its competitors. The Company believes that these Non-GAAP Financial Measures are useful financial metrics to assess its operating performance from period-to-period by excluding certain items that the Company believes are not representative of its core business. These Non-GAAP Financial Measures are not intended to replace, and should not be considered superior to, the presentation of the Company's financial results in accordance with GAAP. The use of the Non-GAAP Financial Measures terms may differ from similar measures reported by other companies and may not be comparable to other similarly titled measures. These Non-GAAP Financial Measures are reconciled from the respective measures under GAAP in the attached appendix. Note on Forward-Looking Statements Some of the information contained in this press release constitutes "forward-looking statements." Forward-looking statements can be identified by words such as "anticipates," "intends," "plans," "seeks," "believes," "estimates," "expects," "projects" and similar references to future periods. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Examples of forward-looking statements include, but are not limited to, statements regarding our future results of operations, financial condition, capital expenditure projects, liquidity, prospects, growth, strategies, capital allocation program (including the stock repurchase program), product and service offerings, expected demand trends, the integration of our recently-acquired Calabrian business and the expected financial contributions relating to such acquisition and our 2026 financial outlook. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you, therefore, against placing any undue reliance on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, regional, national or global political, economic, business, competitive, market and regulatory conditions, including the enactment, schedule and impact of tariffs and trade disputes, currency exchange rates, military conflicts, the effects of inflation, our ability to successfully integrate the Calabrian sulfur dioxide and sulfur derivatives business into our business and realize the benefits of that acquisition and other factors, including those described in the sections titled "Risk Factors" and "Management's Discussion & Analysis of Financial Condition and Results of Operations" in our filings with the SEC, which are available on the SEC's website at www.sec.gov. These forward-looking statements speak only as of the date of this release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law. Appendix Table A-1: Reconciliation of Net Income (Loss) From Continuing Operations to Adjusted EBITDA from Continuing Operations Descriptions to Ecovyst Non-GAAP Reconciliations Appendix Table A-2: Reconciliation of Net Income (Loss) From Continuing Operations and EPS to Adjusted Net Income and Adjusted Diluted Income per share(1) The adjustments to net income (loss) from continuing operations are shown net of applicable tax rates of 25.8% and 23.9% for the six months ended June 30, 2026 and 2025, respectively, except for equity-based compensation and transaction and other related costs. The tax effect of equity-based compensation is derived by removing the tax effect of any equity-based compensation expense disallowed as a result of its inclusion within Section 162(m) of the Internal Revenue Code of 1986, as amended, and adjusting for the tax effect of equity-based compensation windfalls and shortfalls recorded as discrete items. The tax effect of transaction and other related costs is derived by excluding the tax impact of non-deductible transaction costs associated with the Calabrian Acquisition, which are reflected as discrete items within the income tax provision. Appendix Table A-3: Adjusted Free Cash Flow Appendix Table A-4: Net Debt Leverage Ratio View original content to download multimedia:https://www.prnewswire.com/news-releases/ecovyst-reports-second-quarter-2026-results-and-raises-2026-outlook-302843536.html

This article first appeared on GuruFocus. Sales: $250 million in Q2 2026, up $74 million year-over-year, reflecting the pass-through impact of higher sulfur costs, favorable net pricing, and strong demand. Adjusted EBITDA: $53 million in Q2 2026, up 27% year-over-year and within guidance. Adjusted Free Cash Flow: $13 million for the first half of 2026. Net Debt Leverage Ratio: 2.0 times at quarter end, up from 1.2 times at March 31, reflecting debt funding for the Calabrian acquisition. Full-Year 2026 Sales Guidance: $1.02 billion to $1.06 billion, up from prior guidance of $890 million to $970 million (excluding Calabrian). Full-Year 2026 Adjusted EBITDA Guidance: $195 million to $207 million, including $10 million to $12 million from Calabrian in the second half. Full-Year 2026 Adjusted Free Cash Flow Guidance: $45 million to $55 million. Full-Year 2026 Capital Expenditures Guidance: $85 million to $95 million. Full-Year 2026 Adjusted Net Income Guidance: $65 million to $85 million, with adjusted diluted EPS of $0.58 to $0.72. Q3 2026 Adjusted EBITDA Guidance: $54 million to $59 million, including Calabrian. Q4 2026 Adjusted EBITDA Guidance: $48 million to $55 million, including Calabrian. Warning! GuruFocus has detected 5 Warning Signs with ECVT. Is ECVT fairly valued? Test your thesis with our free DCF calculator. Release Date: August 05, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Adjusted EBITDA of $53 million in Q2 2026, up 27% year-over-year, driven by strong demand and favorable pricing. Successful closure of the Calabrian acquisition, which is accretive from day one and expands the portfolio into sulfur dioxide and related derivatives. Double-digit volume growth in virgin sulfuric acid, supported by the Waggaman acquisition and strong mining demand. Raised full-year 2026 adjusted EBITDA guidance to $195-$207 million, reflecting confidence in continued demand stability. Strong balance sheet with net debt leverage at 2.0x, within the target range, and significant liquidity of $176 million. Higher sulfur costs are expected to increase the pass-through effect on sales by approximately $220 million for the full year, impacting working capital. Potential for weaker demand in some industrial applications due to elevated sulfur prices, with a risk of customer destocking if prices moderate. Virgin sulfuric acid volumes are expected to be lower in the second half of 2026 compared to 2025, due to fewer spot sales and planned turnarounds. Increased capital expenditures for the Gulf Coast expansion and Calabrian integration, raising the capex guidance to $85-$95 million. Higher manufacturing, transportation, and general inflation costs partially offset the positive price-to-cost ratio in the quarter. Q: Given the volatility in the sulfur and sulfuric acid markets, how should we think about where contracts coming due later this year may reset, given that roughly 90% of your business is tied to longer-term contracts? A: Kurt Bitting (CEO): While spot sulfur and sulfuric prices are up appreciably year-over-year, the majority of our business is under one-to-three-year contracts for virgin sulfuric acid, with a portion rolling off at the end of each year. As those contracts roll off, we expect they should be negotiated at more favorable pricing, assuming the overall market conditions remain as they are today. Q: Now that the Calabrian transaction is closed and integration is underway, can you quantify or provide an update on targeted cost synergies and how you expect to leverage your existing sales force for cross-selling? A: Kurt Bitting (CEO): We are excited about Calabrian and have safely integrated the business with no customer disruptions, retaining its leadership. We expect to deliver both cost and revenue synergies, likely in the $3 million to $4 million range. We purchased the business for around 8 times EBITDA, and after synergies are implemented, that multiple will step down to around 7 times. Q: Can you clarify if the increase in your underlying guidance (excluding Calabrian) is exclusively coming from one less turnaround in Q4, or are there other incremental puts and takes? A: Kurt Bitting (CEO): We tightened the guidance range for the second consecutive quarter, implying an upward move on the midpoint. This is a combination of some cost items as well as additional favorability we are seeing in certain areas, particularly regeneration, which has been favorable this year due to the strong backdrop in refining. At the midpoint, we are looking at our legacy business moving up about 11% year-on-year. Q: You mentioned sulfur and sulfuric acid costs moderating towards the end of the year. What are your assumptions for how that market might balance out? A: Kurt Bitting (CEO): We believe sulfur prices are largely plateauing at current levels. While international sulfur prices remain elevated, we are starting to see fertilizer producers announce curtailments based on economics. However, mining demand for sulfur remains strong. The blend of curtailments in the fertilizer industry and strong demand from other sectors, particularly mining, should lead to a moderation of sulfur prices. We don't see much room for prices to go up, but we expect moderate decreases rather than a large drop. Q: Given the spread between domestic contract prices and international spot prices, is there flexibility within your system to take advantage of this via exports from your Louisiana-based facilities? A: Kurt Bitting (CEO): We have participated in sulfuric acid exports in the past, and the Waggaman facility brought that capability to our portfolio. Domestic sulfur prices being lower than international prices creates an advantage for US producers and consumers. Our network's largest advantage is the availability of sulfur and our high concentration on the Gulf Coast, where the majority of North American sulfur is produced. Q: You stated the Calabrian acquisition is accretive from day one. Should we think that Calabrian will be free cash flow positive in the first year of ownership, or might there be upfront integration costs? A: Mike Feehan (CFO): We believe the Calabrian acquisition will be cash flow positive. We guided to an EBITDA of $10 million to $12 million for the second half of the year. While there will be additional taxes paid and $100 million of additional debt, we also saw cash interest savings across the portfolio, leaving our overall guidance unchanged. Calabrian is less capital intensive than the legacy business and has a slightly higher EBITDA margin, so it generates a higher level of free cash flow. Any upfront costs will be well outpaced by the synergies we expect over the next year or two. Q: What are you currently seeing in the nylon markets, given concerns about weakness there? A: Kurt Bitting (CEO): For our area in nylon, which is geographically focused on Gulf Coast production, we entered the year expecting it to be flattish. As we sit here midway through the year, that is largely how it is playing out, and we maintain that outlook for the remainder of the year. Q: Can you provide more detail on the demand expectations for regenerated and virgin sulfuric acid for the second half of the year? A: Kurt Bitting (CEO): For regenerated sulfuric acid, we are in the midst of the summer driving season with favorable alkylate economics. We expect refinery utilization to remain high, leading to higher regenerated sulfuric acid volume in the second half with lower unplanned customer downtime than in 2025. For virgin sulfuric acid, we expect relative stability, with continued demand growth in the mining sector driven by copper expansion projects tied to structural electrification. We expect sales into the nylon end use to be relatively flat in 2026. For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Flotek Industries (FTK) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.16 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +100.00%. A quarter ago, it was expected that this oilfield services company would post earnings of $0.13 per share when it actually produced earnings of $0.12, delivering a surprise of -7.69%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Flotek Industries, which belongs to the Zacks Chemical - Specialty industry, posted revenues of $99.37 million for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 46.70%. This compares to year-ago revenues of $58.35 million. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Flotek Industries shares have added about 55.3% since the beginning of the year versus the S&P 500's gain of 11%. While Flotek Industries has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Flotek Industries was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.17 on $71.47 million in revenues for the coming quarter and $0.60 on $281.55 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Specialty is currently in the top 34% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the same industry, Ecovyst (ECVT), is yet to report results for the quarter ended June 2026. The results are expected to be released on August 5. This specialty chemical producer is expected to post quarterly earnings of $0.19 per share in its upcoming report, which represents a year-over-year change of +58.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. Ecovyst's revenues are expected to be $231.01 million, up 15.4% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Flotek Industries, Inc. (FTK) : Free Stock Analysis Report Ecovyst Inc. (ECVT) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

The market for Ecovyst Inc.'s (NYSE:ECVT) shares didn't move much after it posted weak earnings recently. We did some digging, and we believe the earnings are stronger than they seem. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. To properly understand Ecovyst's profit results, we need to consider the US$16m expense attributed to unusual items. It's never great to see unusual items costing the company profits, but on the upside, things might improve sooner rather than later. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And that's hardly a surprise given these line items are considered unusual. If Ecovyst doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year. That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates. Because unusual items detracted from Ecovyst's earnings over the last year, you could argue that we can expect an improved result in the current quarter. Because of this, we think Ecovyst's earnings potential is at least as good as it seems, and maybe even better! On the other hand, its EPS actually shrunk in the last twelve months. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. For example, Ecovyst has 3 warning signs (and 1 which shouldn't be ignored) we think you should know about. This note has only looked at a single factor that sheds light on the nature of Ecovyst's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Ecovyst Inc. recently reported past first-quarter 2026 results, with sales of US$214.95 million and net income of US$4.31 million, alongside the completion of a share repurchase program totaling 33,543,084 shares for US$303.47 million since 2022. The shift from a loss to earnings per share of US$0.04, combined with a meaningful reduction in the share count, may reshape how investors view Ecovyst’s earnings power. We’ll now examine how Ecovyst’s return to profitability and completion of its multi-year buyback program influence the existing investment narrative. We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them. To own Ecovyst, you need to believe its specialty catalysts and Ecoservices businesses can translate volume growth in areas like renewable fuels and mining into sustainable earnings, despite exposure to traditional refining and cyclical end markets. The return to profitability in Q1 2026 and completion of a multi‑year buyback look incrementally positive for near term earnings per share, but they do not fundamentally change the key catalyst around renewable diesel demand or the core risks tied to customer concentration and energy transition. The most relevant recent announcement here is Ecovyst’s completion of its share repurchase program, retiring 26.87% of its shares for US$303.47 million since 2022. Combined with positive earnings in Q1 2026, this materially lowers the share count through which any future benefits from renewable diesel catalysts, the Waggaman facility, or the Kansas City expansion will be shared, while also highlighting that balance sheet flexibility and leverage remain important watchpoints. Yet, beneath the improving earnings headline, investors should still be aware of the concentration risk around a handful of large refinery and mining customers... Read the full narrative on Ecovyst (it's free!) Ecovyst's narrative projects $936.0 million revenue and $163.5 million earnings by 2028. This requires 9.0% yearly revenue growth and a $177.3 million earnings increase from -$13.8 million today. Uncover how Ecovyst's forecasts yield a $10.92 fair value, a 23% downside to its current price. Before this update, the most optimistic analysts were assuming Ecovyst could reach about US$926.7 million of revenue and US$132.9 million of earnings by 2028, which paints a far more upbeat picture than the more cautious consensus. As you weigh Q1’s profitability and the completed buyback, it is worth asking whether that bullish view of faster margin expansion or the concern about high leverage and customer reliance will prove closer to reality. Explore 2 other fair value estimates on Ecovyst - why the stock might be worth 23% less than the current price! Don't just follow the ticker - dig into the data and build a conviction that's truly your own. A great starting point for your Ecovyst research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision. Our free Ecovyst research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Ecovyst's overall financial health at a glance. These stocks are moving-our analysis flagged them today. Act fast before the price catches up: Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution. Uncover the next big thing with 25 elite penny stocks that balance risk and reward. Outshine the giants: these 15 early-stage AI stocks could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ECVT. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]